129 related articles for article (PubMed ID: 1688704)
1. 5HT2 receptor changes in rat cortex and platelets following chronic ritanserin and clorgyline administration.
Twist EC; Mitchell S; Brazell C; Stahl SM; Campbell IC
Biochem Pharmacol; 1990 Jan; 39(1):161-6. PubMed ID: 1688704
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic ritanserin or clorgyline on amine and metabolite levels in rat frontal cortex.
Twist EC; Mitchell SN; Corn TH; Campbell IC
Eur J Pharmacol; 1991 Apr; 196(2):157-60. PubMed ID: 1908389
[TBL] [Abstract][Full Text] [Related]
3. The effect of chronic ritanserin and clorgyline administration on 5-HT2 receptor linked inositol phospholipid hydrolysis.
Twist EC; Brammer MJ; Stephenson JD; Corn TH; Campbell IC
Biochem Pharmacol; 1990 Nov; 40(9):2111-6. PubMed ID: 2122900
[TBL] [Abstract][Full Text] [Related]
4. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA
Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361
[TBL] [Abstract][Full Text] [Related]
5. Chronic effects of tranylcypromine and 4-fluorotranylcypromine on regional brain monoamine metabolism in rats: a comparison with clorgyline.
Greenshaw AJ; Rao TS; Nazarali AJ; Baker GB; Coutts RT
Biol Psychiatry; 1989 Apr; 25(8):1014-20. PubMed ID: 2470425
[TBL] [Abstract][Full Text] [Related]
6. Circadian studies of 5HT2 receptors: effects of clorgyline administration.
Koshikawa N; Durcan MJ; Dunn G; Campbell IC
Pharmacol Biochem Behav; 1988 Jun; 30(2):347-50. PubMed ID: 3174765
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of tryptamine receptors following chronic administration of clorgyline.
Martin LL; Neale RF; Wood PL
Brain Res; 1987 Sep; 419(1-2):239-43. PubMed ID: 3676728
[TBL] [Abstract][Full Text] [Related]
8. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of clorgyline on catecholamine and indoleamine metabolites in the cerebrospinal fluid of rhesus monkeys.
Garrick NA; Scheinin M; Chang WH; Linnoila M; Murphy DL
Biochem Pharmacol; 1984 May; 33(9):1423-7. PubMed ID: 6203542
[TBL] [Abstract][Full Text] [Related]
10. Comparison of [125I]iodolysergic acid diethylamide binding in human frontal cortex and platelet tissue.
Elliott JM; Kent A
J Neurochem; 1989 Jul; 53(1):191-6. PubMed ID: 2723656
[TBL] [Abstract][Full Text] [Related]
11. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
[TBL] [Abstract][Full Text] [Related]
12. Effect of ethanol administration and withdrawal on serotonin receptor subtypes and receptor-mediated phosphoinositide hydrolysis in rat brain.
Pandey SC; Piano MR; Schwertz DW; Davis JM; Pandey GN
Alcohol Clin Exp Res; 1992 Dec; 16(6):1110-6. PubMed ID: 1335222
[TBL] [Abstract][Full Text] [Related]
13. Chronic effects of clomipramine and clorgyline on regional levels of brain amines and acid metabolites in rats.
Mousseau DD; Greenshaw AJ
J Neural Transm; 1989; 75(1):73-9. PubMed ID: 2465373
[TBL] [Abstract][Full Text] [Related]
14. Biochemical profile of risperidone, a new antipsychotic.
Leysen JE; Gommeren W; Eens A; de Chaffoy de Courcelles D; Stoof JC; Janssen PA
J Pharmacol Exp Ther; 1988 Nov; 247(2):661-70. PubMed ID: 2460616
[TBL] [Abstract][Full Text] [Related]
15. Adrenergic regulation of [3H]ketanserin binding sites during immobilization stress in the rat frontal cortex.
Torda T; Murgas K; Cechova E; Kiss A; Saavedra JM
Brain Res; 1990 Sep; 527(2):198-203. PubMed ID: 1701336
[TBL] [Abstract][Full Text] [Related]
16. Acceleration by chronic treatment with clorgyline of the turnover of brain alpha 2-adrenoceptors in normotensive but not in spontaneously hypertensive rats.
Ribas C; Miralles A; García-Sevilla JA
Br J Pharmacol; 1993 Sep; 110(1):99-106. PubMed ID: 8106111
[TBL] [Abstract][Full Text] [Related]
17. Chronic imipramine treatment reduces (+)2-[125I]iodolysergic acid, diethylamide but not 125I-neuropeptide Y binding in layer IV of rat cerebral cortex.
Cummins JT; von Euler G; Fuxe K; Ogren SO; Agnati LF
Neurosci Lett; 1987 Mar; 75(2):152-6. PubMed ID: 3574772
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
19. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
Teitler M; Leonhardt S; Weisberg EL; Hoffman BJ
Mol Pharmacol; 1990 Nov; 38(5):594-8. PubMed ID: 2233696
[TBL] [Abstract][Full Text] [Related]
20. Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
Sanders-Bush E; Breeding M
J Pharmacol Exp Ther; 1988 Oct; 247(1):169-73. PubMed ID: 3139864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
